G. S. Akerman, W. H. Tolleson, K. L. Brown, L. L. Zyzak, E. Mourateva et al., Human Papillomavirus Type 16 E6 and E7 Cooperate to Increase Epidermal Growth Factor Receptor (EGFR) mRNA Levels, Overcoming Mechanisms by which Excessive EGFR Signaling Shortens the Life Span of Normal Human Keratinocytes, Cancer Res, issue.9, pp.61-3837, 2001.

M. Amrani, K. Lalaoui, M. Mzibri, P. Lazo, and M. A. Belabbas, Molecular detection of human papillomavirus in 594 uterine cervix samples from Moroccan women (147 biopsies and 447 swabs), Journal of Clinical Virology, vol.27, issue.3, pp.27-286, 2003.
DOI : 10.1016/S1386-6532(02)00227-5

M. Amrani, K. Lalaoui, M. Mzibri, L. Rouas, L. Benkirane et al., Molecular typing of Human papillomavirus (HPV): Results of a Moroccan study. Maroc Médical, pp.206-211, 2002.

H. Arias-pulido, N. Joste, A. Chavez, C. Y. Muller, D. Dai et al., Absence of epidermal growth factor receptor mutations in cervical cancer, International Journal of Gynecological Cancer, vol.18, issue.4, pp.749-754, 2007.
DOI : 10.1111/j.1525-1438.2007.01111.x

C. Arteaga, Targeting HER1/EGFR: A molecular approach to cancer therapy, Seminars in Oncology, vol.30, issue.3, pp.3-14, 2003.
DOI : 10.1016/S0093-7754(03)70010-4

T. D. Barber, B. Vogelstein, K. W. Kinzler, and V. E. Velculescu, Somatic mutations of EGFR in colorectal cancers and glioblastomas, N Engl J Med, issue.27, pp.351-2883, 2004.

J. Baselga, The EGFR as a target for anticancer therapy???focus on cetuximab, European Journal of Cancer, vol.37, pp.16-22, 2001.
DOI : 10.1016/S0959-8049(01)00233-7

H. Bauer, Y. Ting, C. Greer, J. Chambers, J. Tashiro et al., Genital human papillomavirus infection in female university students as determined by a PCR-based method Selection of HER-2/neu-positive tumor cells in early stage cervical cancer: implications for Herceptin-mediated therapy, JAMA. Gynecol Oncol, vol.256, issue.1, pp.472-91, 1991.

I. Boiko, M. Mitchell, W. Hu, D. K. Pandey, P. Mathevet et al., Epidermal growth factor receptor expression in cervical intraepithelial neoplasia and its modulation during an alphadifluoromethylornithine chemoprevention trial, Clin. Cancer Res, vol.4, issue.6, pp.1383-1391, 1998.

F. X. Bosch, A. Lorincz, N. Munoz, C. J. Meijer, and K. V. Shah, The causal relation between human papillomavirus and cervical cancer, Journal of Clinical Pathology, vol.55, issue.4, pp.244-65, 2002.
DOI : 10.1136/jcp.55.4.244

F. X. Bosch, M. M. Manos, N. Muñoz, M. Sherman, A. M. Jansen et al., Prevalence of Human Papillomavirus in Cervical Cancer, Obstetrical & Gynecological Survey, vol.50, issue.10, pp.796-802, 1995.
DOI : 10.1097/00006254-199510000-00015

E. Carico, M. Atlante, B. Bucci, I. Nofroni, and A. Vecchione, E-Cadherin and ??-Catenin Expression during Tumor Progression of Cervical Carcinoma, Gynecologic Oncology, vol.80, issue.2, pp.156-161, 2001.
DOI : 10.1006/gyno.2000.6035

J. Chang, Y. Tsao, D. Liu, C. Han, W. Lee et al., The Expression of Type I Growth Factor Receptors in the Squamous Neoplastic Changes of Uterine Cervix, Gynecologic Oncology, vol.73, issue.1, pp.62-71, 1999.
DOI : 10.1006/gyno.1998.5301

N. Chaouki, F. X. Bosch, N. Munoz, C. J. Meijer, B. Gueddari et al., The viral origin of cervical cancer in Rabat Epidermal growth factor receptor expression and the presence of human papillomavirus in cervical squamous intraepithelial lesions, Morocco. Int. J. Cancer Int J Gynecol Pathol, vol.75, issue.113, pp.546-554, 1992.

C. L. Chen, S. S. Liu, S. M. Ipb, L. C. Wongb, T. Y. Ng et al., E-cadherin expression is silenced by DNA methylation in cervical cancer cell lines and tumours, European Journal of Cancer, vol.39, issue.4, pp.517-523, 2003.
DOI : 10.1016/S0959-8049(02)00175-2

F. Ciardiello and G. Tortora, EGFR Antagonists in Cancer Treatment, New England Journal of Medicine, vol.358, issue.11, pp.1160-1174, 2008.
DOI : 10.1056/NEJMra0707704

F. Ciardiello and G. Tortora, Epidermal growth factor receptor (EGFR) as a target in cancer therapy: understanding the role of receptor expression and other molecular determinants that could influence the response to anti-EGFR drugs, European Journal of Cancer, vol.39, issue.10, pp.1348-54, 2003.
DOI : 10.1016/S0959-8049(03)00235-1

C. J. De-boer, E. Van-dorst, H. Van-krieken, C. M. Jansenvan-rhijn, S. O. Warnaar et al., Changing Roles of Cadherins and Catenins during Progression of Squamous Intraepithelial Lesions in the Uterine Cervix, The American Journal of Pathology, vol.155, issue.2, pp.505-515, 1999.
DOI : 10.1016/S0002-9440(10)65146-2

A. Dellas, E. Schultheiss, A. C. Almendral, J. Torhorst, and F. Gudat, Assessment of EGFR and TGF-alpha expression in relationship to HPV status and KI-67 distribution in cervical intraepithelial neoplasms, International Journal of Cancer, vol.49, issue.3, pp.69165-169, 1996.
DOI : 10.1002/(SICI)1097-0215(19960621)69:3<165::AID-IJC2>3.0.CO;2-Y

P. W. Derksen, X. Liu, F. Saridin, H. Van-der-gulden, J. Zevenhoven et al., Somatic inactivation of E-cadherin and p53 in mice leads to metastatic lobular mammary carcinoma through induction of anoikis resistance and angiogenesis, Cancer Cell, vol.10, issue.5, pp.437-449, 2006.
DOI : 10.1016/j.ccr.2006.09.013

J. Eluf-neto, M. Booth, N. Munoz, F. X. Bosch, C. J. Meijer et al., Human papillomavirus and invasive cervical cancer in Brazil, British Journal of Cancer, vol.69, issue.1
DOI : 10.1038/bjc.1994.18

L. Frappart, B. Fontanière, E. Lucas, and R. Sankaranarayanan, Histopathology of the uterine cervix, Histopathology and cytopathology of the Uterine Cervix ? Digital Atlas, 2004.

D. K. Gaffney, D. Haslam, A. Tsodikov, E. Hammond, J. Seaman et al., Epidermal growth factor receptor (EGFR) and vascular endothelial growth factor (VEGF) negatively affect overall survival in carcinoma of the cervix treated with radiotherapy, International Journal of Radiation Oncology*Biology*Physics, vol.56, issue.4, pp.922-928, 2003.
DOI : 10.1016/S0360-3016(03)00209-8

G. Galizia, E. Lieto, D. Vita, F. Orditura, M. Castellano et al., Cetuximab, a chimeric human mouse anti-epidermal growth factor receptor monoclonal antibody, in the treatment of human colorectal cancer, Oncogene, vol.12, issue.25, pp.3654-3660, 2007.
DOI : 10.1038/35052073

S. R. Ghaffari, T. Sabokbar, H. Mollahajian, J. Dastan, F. Ramezanzadeh et al., Prevalence of human papillomavirus genotypes in women with normal and abnormal cervical cytology in Iran, Asian Pac J Cancer Prev, vol.7, issue.4, pp.529-532, 2006.

M. L. Gonzalgo, T. Hayashida, C. M. Bender, M. M. Pao, Y. C. Tsai et al., The role of DNA methylation in expression of the p19/p16 locus in human bladder cancer cell lines, Cancer Res, vol.58, pp.1245-1252, 1998.

B. E. Gould-rothberg and M. B. Bracken, E-cadherin Immunohistochemical Expression as a Prognostic Factor in Infiltrating Ductal Carcinoma of the Breast: a Systematic Review and Meta-Analysis, Breast Cancer Research and Treatment, vol.329, issue.2, pp.139-148, 2006.
DOI : 10.1007/s10549-006-9248-2

C. Gridelli, M. A. Bareschino, C. Schettino, A. Rossi, P. Maione et al., Erlotinib in Non-Small Cell Lung Cancer Treatment: Current Status and Future Development, The Oncologist, vol.12, issue.7, pp.840-849, 2007.
DOI : 10.1634/theoncologist.12-7-840

R. Herrero, P. E. Castle, M. Schiffman, M. C. Bratti, A. Hildesheim et al., Epidemiologic Profile of Type???Specific Human Papillomavirus Infection and Cervical Neoplasia in Guanacaste, Costa Rica, The Journal of Infectious Diseases, vol.191, issue.11, pp.191-1796, 2005.
DOI : 10.1086/428850

S. Hirohashi, Inactivation of the E-Cadherin-Mediated Cell Adhesion System in Human Cancers, The American Journal of Pathology, vol.153, issue.2, pp.333-339, 1998.
DOI : 10.1016/S0002-9440(10)65575-7

G. Hu, W. Liu, J. Mendelsohn, L. M. Ellis, R. Radinsky et al., Expression of epidermal growth factor receptor and human papillomavirus E6/E7 proteins in cervical carcinoma cells. J. Natl. Cancer Inst Up-regulation of expression and lack of 5' CpG island hypermethylation of p16 INK4a in HPV-positive cervical carcinomas, Grandis, J.R. and Argiris, A. Therapies directed against epidermal growth factor receptor in aerodigestive carcinomas, pp.1271-1276, 1997.

P. Kay, R. Soeters, J. Nevin, L. Denny, C. M. Dehaeck et al., High prevalence of HPV 16 in South African women with cancer of the cervix and cervical intraepithelial neoplasia, Journal of Medical Virology, vol.43, issue.2, pp.265-273, 2003.
DOI : 10.1002/jmv.10479

W. Kedzia, M. Schmidt, A. Frankowski, and M. Spaczynski, Immunohistochemical assay of p53, cyclin D1, c-erbB2, EGFR and Ki-67 proteins in HPV-positive and HPVnegative cervical cancers, Folia Histochem Cytobiol, vol.40, issue.1, pp.37-41, 2002.

G. E. Kim, Y. B. Kim, N. H. Cho, H. C. Chung, H. R. Pyo et al., Synchronous Coexpression of Epidermal Growth Factor Receptor and Cyclooxygenase-2 in Carcinomas of the Uterine Cervix: A Potential Predictor of Poor Survival, Clinical Cancer Research, vol.10, issue.4, pp.1366-1374, 2004.
DOI : 10.1158/1078-0432.CCR-0497-03

R. Klaes, T. Friedrich, D. Spitkovsky, R. Ridder, W. Rudy et al., Overexpression of p16INK4A as a specific marker for dysplastic and neoplastic epithelial cells of the cervix uteri, International Journal of Cancer, vol.70, issue.2, pp.276-284, 2001.
DOI : 10.1002/ijc.1174

C. M. Lee, R. J. Lee, E. Hammond, A. Tsodikov, M. Dodson et al., Expression of HER2neu (c-erbB-2) and epidermal growth factor receptor in cervical cancer: prognostic correlation with clinical characteristics, and comparison of manual and automated imaging analysis, Gynecologic Oncology, vol.93, issue.1, pp.93-209, 2004.
DOI : 10.1016/j.ygyno.2004.01.006

C. M. Lee, D. C. Shrieve, K. A. Zempolich, R. J. Lee, E. Hammond et al., Correlation between human epidermal growth factor receptor family (EGFR, HER2, HER3, HER4), phosphorylated Akt (P-Akt), and clinical outcomes after radiation therapy in carcinoma of the cervix, phosphorylated Akt (P-Akt), and clinical outcomes after radiation therapy in carcinoma of the cervix, pp.415-421, 2005.
DOI : 10.1016/j.ygyno.2005.05.045

T. W. Leung, A. N. Cheung, D. K. Cheng, L. C. Wong, and H. Ngan, Expressions of c-erbB-2, epidermal growth factor receptor and pan-ras proto-oncogenes in adenocarcinoma of the cervix: Correlation with clinical prognosis, Oncology Reports, vol.8, issue.5, pp.1159-1164, 2001.
DOI : 10.3892/or.8.5.1159

X. Liu, A. Clements, and K. Zhao, Structure of the Human Papillomavirus E7 Oncoprotein and Its Mechanism for Inactivation of the Retinoblastoma Tumor Suppressor, Journal of Biological Chemistry, vol.281, issue.1, pp.578-586, 2006.
DOI : 10.1074/jbc.M508455200

A. Marchetti, C. Martella, L. Felicioni, F. Barassi, S. Salvatore et al., Mutations in Non???Small-Cell Lung Cancer: Analysis of a Large Series of Cases and Development of a Rapid and Sensitive Method for Diagnostic Screening With Potential Implications on Pharmacologic Treatment, Journal of Clinical Oncology, vol.23, issue.4, pp.857-865, 2005.
DOI : 10.1200/JCO.2005.08.043

M. Mareel, G. Berx, F. Van-roy, and M. Bracke, Cadherin/catenin complex: A target for antiinvasive therapy?, Journal of Cellular Biochemistry, vol.121, issue.4, pp.524-530, 1996.
DOI : 10.1002/(SICI)1097-4644(19960616)61:4<524::AID-JCB5>3.0.CO;2-Q

R. Marzano, G. Corrado, R. Merola, C. Sbiroli, F. Guadagni et al., Analysis of chromosomes 3, 7, X and the EGFR gene in uterine cervical cancer progression, Eur J Cancer, issue.10, pp.40-1624, 2004.

S. P. Mathur, R. S. Mathur, P. F. Rust, and R. C. Young, Human Papilloma Virus (HPV)-E6/E7 and Epidermal Growth Factor Receptor (EGF-R) Protein Levels in Cervical Cancer and Cervical Intraepithelial Neoplasia (CIN), American Journal of Reproductive Immunology, vol.46, issue.4, pp.280-287, 2001.
DOI : 10.1034/j.1600-0897.2001.d01-14.x

M. Meftah-el-khair, M. Mzibri, M. , R. Ait-mhand, R. et al., Molecular detection and genotyping of human papillomavirus in cervical carcinoma biopsies in an area of high incidence of cancer from Moroccan women, Journal of Medical Virology, vol.94, issue.4, pp.678-684, 2009.
DOI : 10.1002/jmv.21279

J. Mendelsohn and J. Baselga, Status of Epidermal Growth Factor Receptor Antagonists in the Biology and Treatment of Cancer, Journal of Clinical Oncology, vol.21, issue.14, pp.2787-99, 2003.
DOI : 10.1200/JCO.2003.01.504

W. A. Messersmith and M. Hidalgo, Panitumumab, a Monoclonal Anti Epidermal Growth Factor Receptor Antibody in Colorectal Cancer: Another One or the One?, Clinical Cancer Research, vol.13, issue.16, pp.4664-4666, 2007.
DOI : 10.1158/1078-0432.CCR-07-0065

K. Milde-langosch, S. Riethdorf, A. Kraus-poppinghaus, L. Riethdorf, and T. Loning, Expression of cyclindependent kinase inhibitors p16MTS1, p21WAF1, and p27KIP1 in HPV-positive and HPV-negative cervical adenocarcinomas. Virchows Arch, pp.55-61, 2001.

N. Nagai, T. Oshita, T. Fujii, H. Kioka, Y. Katsube et al., Prospective analysis of DNA ploidy, proliferative index and epidermal growth factor receptor as prognostic factors for pretreated uterine cancer., Oncology Reports, vol.7, issue.3, pp.551-559, 2000.
DOI : 10.3892/or.7.3.551

H. Y. Ngan, A. N. Cheung, S. S. Liu, D. K. Cheng, T. Y. Ng et al., Abnormal Expression of Epidermal Growth Factor Receptor and c-erbB2 in Squamous Cell Carcinoma of the Cervix: Correlation with Human Papillomavirus and Prognosis, Tumor Biology, vol.22, issue.3, pp.22-176, 2001.
DOI : 10.1159/000050613

C. Ngelangel, N. Muñoz, F. X. Bosch, G. M. Limson, M. R. Festin et al., Causes of cervical cancer in the Philippines: a case-control study, J Natl Cancer Inst, issue.1, pp.90-133, 1998.

R. Nicholson, J. Gee, and M. Harper, EGFR and cancer prognosis, European Journal of Cancer, vol.37, issue.4, pp.9-15, 2001.
DOI : 10.1016/S0959-8049(01)00231-3

N. Normanno, C. Bianco, A. De-luca, M. R. Maiello, and D. S. Salomon, Target-based agents against ErbB receptors and their ligands: a novel approach to cancer treatment, Endocrine Related Cancer, vol.10, issue.1, pp.1-21, 2003.
DOI : 10.1677/erc.0.0100001

J. G. Paez, P. A. Janne, J. C. Lee, S. Tracy, H. Greulich et al., EGFR Mutations in Lung Cancer: Correlation with Clinical Response to Gefitinib Therapy, Science, vol.304, issue.5676, pp.1497-1500, 2004.
DOI : 10.1126/science.1099314

W. Pao, V. Miller, M. Zakowski, J. Doherty, K. Politi et al., EGF receptor gene mutations are common in lung cancers from "never smokers" and are associated with sensitivity of tumors to gefitinib and erlotinib, Proceedings of the National Academy of Sciences, vol.101, issue.36, pp.13306-13311, 2004.
DOI : 10.1073/pnas.0405220101

D. Parkin, P. Pisani, J. Ferlay, S. Riethdorf, E. F. Neffen et al., Estimates of the worldwide incidence of 25 major cancers in 1990, International Journal of Cancer, vol.64, issue.6, pp.827-841, 1999.
DOI : 10.1002/(SICI)1097-0215(19990315)80:6<827::AID-IJC6>3.0.CO;2-P

P. A. Rolon, J. S. Smith, N. Munoz, S. J. Klug, R. Herrero et al., Human papillomavirus infection and invasive cervical cancer in Paraguay, International Journal of Cancer, vol.189, issue.4, pp.486-491, 2000.
DOI : 10.1002/(SICI)1097-0215(20000215)85:4<486::AID-IJC7>3.0.CO;2-S

D. S. Salomon, R. Brandt, F. Ciardiello, and N. Normanno, Epidermal growth factor-related peptides and their receptors in human malignancies, Critical Reviews in Oncology/Hematology, vol.19, issue.3, pp.183-232, 1995.
DOI : 10.1016/1040-8428(94)00144-I

J. Sambrook, E. F. Fritsch, and T. Maniatis, Molecular Cloning: A laboratory manual, 1989.

C. Santos, N. Munoz, S. Klug, M. Almonte, I. Guerrero et al., HPV types and cofactors causing cervical cancer in Peru, British Journal of Cancer, vol.189, issue.7, pp.966-71, 2001.
DOI : 10.1054/bjoc.2001.1948

S. Sharma, D. Bell, J. Settleman, and D. Haber, Epidermal growth factor receptor mutations in lung cancer, Nature Reviews Cancer, vol.64, issue.3, pp.169-181, 2007.
DOI : 10.1038/nrc2088

N. Sizemore, C. K. Choo, R. L. Eckert, E. A. Rorke, M. H. Stoler et al., Transcriptional Regulation of the EGF Receptor Promoter by HPV16 and Retinoic Acid in Human Ectocervical Epithelial Cells, Experimental Cell Research, vol.244, issue.1, pp.349-56, 1993.
DOI : 10.1006/excr.1998.4179

H. Trottier, S. Mahmud, M. C. Costa, J. P. Sobrinho, E. D. Franco et al., Human Papillomavirus Infections with Multiple Types and Risk of Cervical Neoplasia, Japanese. Lung Cancer, pp.1274-1279, 2006.
DOI : 10.1158/1055-9965.EPI-06-0129

N. Wentzensen, C. Bergeron, F. Cas, S. Vinokurova, and M. Doeberitz, Triage of women with ASCUS and LSIL cytology, Cancer, vol.188, issue.1, pp.58-66, 2007.
DOI : 10.1002/cncr.22420

T. C. Wright, L. Denny, L. Kuhn, A. Pollack, and A. Lorincz, HPV DNA Testing of Self-collected Vaginal Samples Compared With Cytologic Screening to Detect Cervical Cancer, JAMA, vol.283, issue.1, pp.81-86, 2000.
DOI : 10.1001/jama.283.1.81

B. Zhang, A. Srirangam, D. A. Potter, and A. Roman, HPV16 E5 protein disrupts the c-Cbl???EGFR interaction and EGFR ubiquitination in human foreskin keratinocytes, Oncogene, vol.9, issue.15, pp.2585-2588, 2005.
DOI : 10.1038/sj.onc.1208453

X. Zhu, C. A. Rottkamp, A. Hartzler, Z. Sun, A. Takeda et al., Activation of MKK6, an upstream activator of p38, in Alzheimer's disease, Journal of Neurochemistry, vol.76, issue.2, pp.311-318, 2001.
DOI : 10.1046/j.1471-4159.2001.00597.x